1275733

Inspection Details

Classification

No Action Indicated (NAI) (NAI)

End Date

July 11, 2025

Fiscal Year

2025

Product Type

Drugs

Project Area

Bioresearch Monitoring

Location

Washington, DC (United States)

Additional Details